Anixa Biosciences re-elects four directors and ratifies auditor at 2024 annual meeting

Anixa Biosciences Inc

Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. re-elected as directors with 7.9M-7.7M votes for.
Executive compensation approved on non-binding advisory basis: 6.0M for, 1.8M against, 123K abstain.
Haskell & White LLP ratified as independent auditor for FY ending Oct 31, 2024: 18.4M for, 80K against, 51K abstain.
Total shares present at meeting: 18,521,786 out of 31,711,753 eligible shares (58.4% turnout).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Anixa Biosciences Inc shareholders approved Approval, by non-binding advisory vote, of the Company's executive compensation at the 2024-03-21 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2024-03-21

Exact text from the filing

The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 6,010,385 1,843,353 123,415 10,544,633

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Anixa Biosciences Inc shareholders approved Ratification of the appointment of independent registered public accounting firm at the 2024-03-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2024-03-21

Exact text from the filing

The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 18,390,227 80,392 51,167 -

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Anixa Biosciences Inc shareholders approved Election of directors at the 2024-03-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2024-03-21

Exact text from the filing

The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Vote Dr. Amit Kumar 7,894,499 82,654 10,544,633 Dr. Arnold Baskies 7,857,006 120,147 10,544,633 Emily Gottschalk 7,853,085 124,068 10,544,633 Lewis H. Titterton, Jr. 7,718,162 258,991 10,544,633

View on SEC.gov

425 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Anixa Biosciences Inc filing history →

Source: SEC EDGAR

accession 0001493152-24-010995

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.